These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 16691484)

  • 1. Ectopic localization of mitochondrial ATP synthase: a target for anti-angiogenesis intervention?
    Kenan DJ; Wahl ML
    J Bioenerg Biomembr; 2005 Dec; 37(6):461-5. PubMed ID: 16691484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiostatin-like activity of a monoclonal antibody to the catalytic subunit of F1F0 ATP synthase.
    Chi SL; Wahl ML; Mowery YM; Shan S; Mukhopadhyay S; Hilderbrand SC; Kenan DJ; Lipes BD; Johnson CE; Marusich MF; Capaldi RA; Dewhirst MW; Pizzo SV
    Cancer Res; 2007 May; 67(10):4716-24. PubMed ID: 17510399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Inhibitor of the F1 subunit of ATP synthase (IF1) modulates the activity of angiostatin on the endothelial cell surface.
    Burwick NR; Wahl ML; Fang J; Zhong Z; Moser TL; Li B; Capaldi RA; Kenan DJ; Pizzo SV
    J Biol Chem; 2005 Jan; 280(3):1740-5. PubMed ID: 15528193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiostatin is directly cytotoxic to tumor cells at low extracellular pH: a mechanism dependent on cell surface-associated ATP synthase.
    Chi SL; Pizzo SV
    Cancer Res; 2006 Jan; 66(2):875-82. PubMed ID: 16424020
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial cell surface F1-F0 ATP synthase is active in ATP synthesis and is inhibited by angiostatin.
    Moser TL; Kenan DJ; Ashley TA; Roy JA; Goodman MD; Misra UK; Cheek DJ; Pizzo SV
    Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6656-61. PubMed ID: 11381144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic ATP synthase in endothelial cells: a novel cardiovascular therapeutic target.
    Fu Y; Zhu Y
    Curr Pharm Des; 2010; 16(37):4074-9. PubMed ID: 21247400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of action of angiostatin: can you teach an old dog new tricks?
    Moser TL; Stack MS; Wahl ML; Pizzo SV
    Thromb Haemost; 2002 Mar; 87(3):394-401. PubMed ID: 11916069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of microenvironmental extracellular pH and extracellular matrix proteins on angiostatin's activity and on intracellular pH.
    Wahl ML; Grant DS
    Gen Pharmacol; 2000 Nov; 35(5):277-85. PubMed ID: 11888684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiostatin binds ATP synthase on the surface of human endothelial cells.
    Moser TL; Stack MS; Asplin I; Enghild JJ; Højrup P; Everitt L; Hubchak S; Schnaper HW; Pizzo SV
    Proc Natl Acad Sci U S A; 1999 Mar; 96(6):2811-6. PubMed ID: 10077593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual functions of a monoclonal antibody against cell surface F1F0 ATP synthase on both HUVEC and tumor cells.
    Zhang X; Gao F; Yu LL; Peng Y; Liu HH; Liu JY; Yin M; Ni J
    Acta Pharmacol Sin; 2008 Aug; 29(8):942-50. PubMed ID: 18664327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal and pharmacological characterization of angiostatin release and generation by human platelets: implications for endothelial cell migration.
    Radziwon-Balicka A; Moncada de la Rosa C; Zielnik B; Doroszko A; Jurasz P
    PLoS One; 2013; 8(3):e59281. PubMed ID: 23555012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of tumor cell surface ATP synthesis by pigment epithelium-derived factor: implications for antitumor activity.
    Deshpande M; Notari L; Subramanian P; Notario V; Becerra SP
    Int J Oncol; 2012 Jul; 41(1):219-27. PubMed ID: 22504705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of Nm23H2 gene product (NDPK-B) by angiostatin, polyphenols and nucleoside analogs.
    Buxton IL
    Proc West Pharmacol Soc; 2008; 51():30-4. PubMed ID: 19544670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct targeting of tumor cell F(1)F(0) ATP-synthase by radioiodine angiostatin in vitro and in vivo.
    Jung KH; Song SH; Paik JY; Koh BH; Choe YS; Lee EJ; Kim BT; Lee KH
    Cancer Biother Radiopharm; 2007 Oct; 22(5):704-12. PubMed ID: 17979573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Numerical simulation of the inhibitory effect of angiostatin on metastatic tumor angiogenesis and microenvironment.
    Zhao G; Yan W; Chen E; Yu X; Cai W
    Bull Math Biol; 2013 Feb; 75(2):274-87. PubMed ID: 23292363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thalidomide and angiostatin inhibit tumor growth in a murine xenograft model of human cervical cancer.
    Downs LS; Rogers LM; Yokoyama Y; Ramakrishnan S
    Gynecol Oncol; 2005 Aug; 98(2):203-10. PubMed ID: 15975645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-angiogenesis mediated by angiostatin K1-3, K1-4 and K1-4.5. Involvement of p53, FasL, AKT and mRNA deregulation.
    Chen YH; Wu HL; Li C; Huang YH; Chiang CW; Wu MP; Wu LW
    Thromb Haemost; 2006 Apr; 95(4):668-77. PubMed ID: 16601838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different ways to antiangiogenesis by angiostatin and suramin, and quantitation of angiostatin-induced antiangiogenesis.
    Bahramsoltani M; Plendl J
    APMIS; 2007 Jan; 115(1):30-46. PubMed ID: 17223849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiostatin's molecular mechanism: aspects of specificity and regulation elucidated.
    Wahl ML; Kenan DJ; Gonzalez-Gronow M; Pizzo SV
    J Cell Biochem; 2005 Oct; 96(2):242-61. PubMed ID: 16094651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Matrix metalloproteinase-19 inhibits growth of endothelial cells by generating angiostatin-like fragments from plasminogen.
    Brauer R; Beck IM; Roderfeld M; Roeb E; Sedlacek R
    BMC Biochem; 2011 Jul; 12():38. PubMed ID: 21787393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.